did the fda ban semaglutide Novo Nordisk expands Wegovy access as bans copies The FDA's Decision to Ban

Regulators protecting patients in the news In a January warning letter to an Arizona facility that produces kids' bubblegum toothpaste, the FDA cited significant CGMP violations, including inadequate controls to prevent cross-contamination from potent ingredients, insufficient cleaning validation, release of drug products without proper laboratory testing, and a lack of effective quality unit oversight

Martin Marshall (@MartinRCGP) Tweeted: 2 emails from friends overnight saying the same thing, one a GP and local NHS leader and the other a clinical academic

It is an order-of-magnitude difference in GLP-1 receptor activation intensity

Who Should and Shouldn't Use GLP-1 Agonists: Eligibility and Safety Boundaries GLP-1 agonists are generally safe for adults with type 2 diabetes or obesity seeking weight reduction

The campaign was published on August 21, and within just three days, Zocdoc noted a whopping 27% increase in appointment bookings for GLP-1s